Skip to main content

RX · BioSyent Inc. · Financials

16.8500 CAD -0.2000 (-1.17%) At close · Nov 3 Intraday price with Plus
Market Cap
190.39M CAD
Shares
11.23M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

No Financial Data

No structured financial facts have been ingested for this stock yet.